Klor-con and Ubrelvy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Klor-con (potassium chloride) and Ubrelvy (ubrogepant). Common drug interactions include urinary tract infection among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Klor-con and Ubrelvy. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.

What is Ubrelvy?

Ubrelvy has active ingredients of ubrogepant. eHealthMe is studying from 3,585 Ubrelvy users. Check the latest studies of Ubrelvy.

On Jul, 10, 2026

24 people who take Klor-con and Ubrelvy together, and have interactions are studied.

What are the common drug interactions of Klor-Con and Ubrelvy, by gender? *:

female:

Urinary tract infection
Vein disorder
Visual impairment
Nausea (feeling of having an urge to vomit)
Irritable bowel syndrome
Flushing (the warm, red condition of human skin)
Migraine (headache)
Vomiting
Allergy to chemicals
Dehydration (dryness resulting from the removal of water)

male:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Dyspnoea (difficult or laboured respiration)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Face injury
Fall
Back pain
Bacterial infection
Dysphonia (speech disorder attributable to a disorder of phonation)
Neck pain
Oropharyngeal pain

What are the common drug interactions of Klor-Con and Ubrelvy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Fatigue (feeling of tiredness)
Headache (pain in head)
Heart rate increased
Nausea (feeling of having an urge to vomit)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Tinnitus (a ringing in the ears)
Tremor (trembling or shaking movements in one or more parts of your body)
Visual impairment

30-39:

n/a

40-49:

Nausea (feeling of having an urge to vomit)
Allergy to chemicals
Dehydration (dryness resulting from the removal of water)
Dizziness
Flushing (the warm, red condition of human skin)
Irritable bowel syndrome
Memory impairment
Migraine (headache)
Pain in jaw
Polymenorrhoea (menstrual disorder)

50-59:

Malaise (a feeling of general discomfort or uneasiness)
Nasopharyngitis (inflammation of the nasopharynx)

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Dyspnoea (difficult or laboured respiration)
Ear disorder
Irritable bowel syndrome
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Blood iron decreased
Face injury
Fall
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma

What are the existing conditions these people have? *

Migraine (headache): 8 people, 33.33%
Nausea (feeling of having an urge to vomit): 5 people, 20.83%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 16.67%
Drowsiness: 4 people, 16.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 16.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 12.50%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 2 people, 8.33%
Rashes (redness): 2 people, 8.33%
Pain: 2 people, 8.33%
Neuropathy Peripheral (surface nerve damage): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Klor-con and Ubrelvy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously